Liting Guo

2PUBLICATIONS
2CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Dec 03, 2025
A multicenter, observational study to evaluate the safety of restarting antitumor therapy recovered from COVID-19.

Liting Guo, Chenfei Zhou, Wenqi Xi

|Oct 06, 2023
Neratinib for HER2-positive breast cancer with an overlooked option.

Liting Guo, Weiwei Shao, Chenfei Zhou

Pageof 1